Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10576-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10576-1-AP, RRID:AB_2172805
- Product name
- RPN2 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated RPN2 antibody (Cat. #10576-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references [WITHDRAWN] Hexokinase-1 mitochondrial dissociation and protein O-GlcNAcylation drive heart failure with preserved ejection fraction.
The N(6)-methyladenosine-mediated lncRNA WEE2-AS1 promotes glioblastoma progression by stabilizing RPN2.
RPN2 Predicts Poor Prognosis and Promotes Bladder Cancer Growth and Metastasis via the PI3K-Akt Pathway.
Downregulation of ribophorin II suppresses tumor growth, migration, and invasion of nasopharyngeal carcinoma.
Tatekoshi Y, Shapiro JS, Liu M, Bianco GM, Tatekoshi A, De Jesus A, Koleini N, Wasserstrom JA, Dillmann WH, Weinberg SE, Ardehali H
Research square 2023 Jan 25;
Research square 2023 Jan 25;
The N(6)-methyladenosine-mediated lncRNA WEE2-AS1 promotes glioblastoma progression by stabilizing RPN2.
Li B, Zhao R, Qiu W, Pan Z, Zhao S, Qi Y, Qiu J, Zhang S, Guo Q, Fan Y, Xu H, Li M, Li G, Xue H
Theranostics 2022;12(14):6363-6379
Theranostics 2022;12(14):6363-6379
RPN2 Predicts Poor Prognosis and Promotes Bladder Cancer Growth and Metastasis via the PI3K-Akt Pathway.
Han C, Chen S, Ma H, Wen X, Wang Z, Xu Y, Jin X, Yu X, Wang M
OncoTargets and therapy 2021;14:1643-1657
OncoTargets and therapy 2021;14:1643-1657
Downregulation of ribophorin II suppresses tumor growth, migration, and invasion of nasopharyngeal carcinoma.
Hong F, Li Y, Ni H, Li J
OncoTargets and therapy 2018;11:3485-3494
OncoTargets and therapy 2018;11:3485-3494
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The RPN2 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human RPN2. This antibody recognizes human, mouse, rat antigen. The RPN2 antibody has been validated for the following applications: ELISA, IHC analysis.